Stretch Marks Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
Persistence Market Research는 최근 세계 스트레치 마크 치료 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회 및 과제를 포함한 주요 시장 역학을 철저히 평가하고 시장 구조에 대한 심층적인 통찰력을 제공합니다.
주요 인사이트
- 스트레치 마크 치료 시장 규모(2024E) : 29억 달러
- 예상 시장 가치(2033F) : 46억 달러
- 세계 시장 성장률(2024-2033년 CAGR) : 5.3%
스트레치 마크 치료 시장 - 보고서 범위 :
스트레치 마크는 선조 또는 선조체라고도 하는 피부의 급격한 확장으로 인해 발생하는 흔한 피부 질환입니다. 튼살 치료 시장에는 국소 치료, 레이저 치료, 외과적 개입 등 다양한 치료 옵션이 있습니다. 이러한 치료는 튼살을 눈에 띄지 않게 하고 피부 결을 개선하는 것을 목표로 합니다. 이 시장은 미용 개선을 원하는 개인, 전문 치료를 제공하는 의료 서비스 제공업체, 고급 솔루션을 제공하는 미용 클리닉 등 다양한 고객에게 서비스를 제공합니다. 시장 성장의 원동력은 피부 미용에 대한 인식 증가, 생활습관 및 호르몬 변화로 인한 스트레치 마크의 유병률 증가, 치료 기술의 발전입니다.
시장 성장 촉진요인 :
세계 튼살 치료 시장은 효과적인 치료 옵션의 가용성에 대한 인식이 높아짐에 따라 몇 가지 중요한 요인에 의해 주도되고 있습니다. 임신, 급격한 체중 증가, 사춘기 등의 요인으로 인한 튼살 발생이 증가하면서 치료 수요 증가에 기여하고 있습니다. 비침습적 레이저 치료 및 강화된 국소 제제 개발과 같은 기술 발전은 치료 효과와 환자 편의성을 향상시키고 있습니다. 또한, 미적 감각의 향상과 미용 성형에 대한 관심이 높아지면서 시장 확대의 원동력이 되고 있습니다. 가처분 소득 증가와 개인 맞춤형 스킨케어에 대한 관심 증가는 시장 성장에 더욱 기여하고 있습니다.
시장 성장 억제요인 :
유망한 성장 전망에도 불구하고, 튼살 치료 시장은 비용과 접근성 문제에 직면해 있습니다. 레이저 치료나 외과적 개입과 같은 고급 치료는 고가의 비용으로 인해 일부 개인은 접근하기 어려울 수 있습니다. 또한, 치료 효과는 개인의 피부 상태와 튼살의 정도에 따라 달라질 수 있으며, 이는 환자의 만족도와 치료 결과에 영향을 미칠 수 있습니다. 시장에서는 규제 준수와 치료의 효과와 안전성을 검증하기 위한 지속적인 연구의 필요성에 대한 도전 과제에 직면해 있습니다.
시장 기회 :
스트레치 마크 치료 시장은 기술 혁신, 인구 동향, 소비자 선호도 변화로 인해 큰 성장 기회를 맞이하고 있습니다. 고주파 및 초음파 치료와 같은 새로운 기술의 통합으로 치료 옵션이 강화되고 있습니다. 개인화된 스킨케어 솔루션에 대한 관심이 높아지고 최소침습적 시술의 인기가 높아짐에 따라 시장 참여자들에게 새로운 길을 열어줄 것입니다. 전략적 파트너십, 연구 개발에 대한 투자, 저렴하고 효과적인 치료법의 도입은 새로운 기회를 활용하고 시장 리더십을 유지하는 데 필수적입니다.
본 보고서에서 다룬 주요 질문들
- 세계 스트레치 마크 치료 시장의 성장을 가속하는 주요 요인은?
- 다양한 환자층에서 채택을 촉진하고 있는 치료의 유형과 용도는 무엇인가?
- 기술의 발전은 스트레치 마크 치료 시장 경쟁 구도를 어떻게 바꾸고 있는가?
- 스트레치 마크 치료 시장에 기여하는 주요 기업은 누구이며, 시장의 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
- 세계 스트레치 마크 치료 시장의 새로운 트렌드와 전망은?
목차
제1장 주요 요약
제2장 시장 개요
- 시장 범위/분류
- 시장의 정의/범위/제한
- 포함과 제외
제3장 주요 시장 동향
- 시장에 영향을 미치는 주요 동향
- 치료 유형 혁신/개발 동향
제4장 중요 성공 요인
- Porter의 Five Forces 분석
- PESTEL 분석
- 피부과의/미용성형외과의, 주요 국가
- 피부과/미용성형외과 클리닉, 주요 국가
- 지역별 미용 시술 건수
- 지역별 임신수
- 지불자 믹스 분석
- 주요 기업의 프로모션 전략
- 헬스케어비 상환과 자금조달 구조
- 규제 시나리오
- 상위 시장 분석
제5장 시장 배경
- 거시경제 요인
- 예측 요인 - 관련성과 영향
- 역학
제6장 COVID-19 위기 - 영향 평가
- COVID-19와 영향 분석
- 치료 유형별
- 스트레치 마크 유형별
- 최종사용자별
- 지역별
- 2023년 시장 시나리오
제7장 세계 시장 수요(금액 또는 규모) 분석
- 시장 매출 분석, 2019-2023년
- 시장 매출 예측, 2024-2033년
제8장 치료 유형별 : 세계 시장 분석
- 서론/주요 조사 결과
- 시장 규모(금액 및 수량) 분석, 2019-2023년
- 시장 규모(금액 및 수량) 분석과 예측, 2024-2033년
- 외용약
- 시술 치료
- Radiofrequency Therapy
- Nonablative Laser Fractional Resurfacing
- Ablative Laser Resurfacing
- Infrared Devices/Radiations
- Dermabrasion
- Chemical Peel
- 치료 유형별 시장의 매력 분석
제9장 스트레치 마크 유형별 : 세계 시장 분석
- 서론/주요 조사 결과
- 시장 규모(금액) 분석, 2019-2023년
- 시장 규모(금액) 분석과 예측, 2024-2033년
- Striae Atrophicans (Thinned Skin)
- Striae Gravidarum (Post Pregnancy)
- Striae Distensae (Stretched Skin)
- Striae Rubrae (Red)
- Striae Albae (White)
- Striae Nigra (Black)
- Striae Caerulea (Dark Blue)
- 스트레치 마크 유형별 : 시장의 매력 분석
제10장 최종사용자별 : 세계 시장 분석
- 서론/주요 조사 결과
- 시장 규모(금액) 분석, 2019-2023년
- 시장 규모(금액) 분석과 예측, 2024-2033년
- 병원
- 피부과 클리닉
- 미용 클리닉
- 웰니스＆스파 센터
- 홈케어 환경
- 최종사용자별 시장의 매력 분석
제11장 지역별 : 세계 시장 분석
- 서론
- 시장 규모(금액) 분석, 2019-2023년
- 시장 규모(금액) 분석과 예측, 2024-2033년
- 북미
- 라틴아메리카
- 유럽
- 남아시아
- 동아시아
- 오세아니아
- 중동 및 아프리카(중동 및 아프리카)
- 지역별 시장의 매력 분석
제12장 북미 시장 분석
제13장 라틴아메리카 시장 분석
제14장 유럽 시장 분석
제15장 남아시아 시장 분석
제16장 동아시아 시장 분석
제17장 오세아니아 시장 분석
제18장 중동 및 아프리카 시장 분석
제19장 시장 구조 분석
- 기업 Tier별 시장 분석
- 주요 기업의 시장 점유율 분석
- 시장 입지 분석
제20장 경쟁 분석
- 경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 상세
- Weleda
- Clarins
- basq NYC
- Body Merry
- Himalaya Global Holdings Ltd.
- Stratpharma AG(Stratpharma Inc.)
- Browne Drug Co., Inc.(Palmer's)
- Mederma(HRA Pharma)
- Givaudan SA
- NEOSTRATA COMPANY, INC.(Johnson &Johnson Services, Inc.)
- Bio-Oil(Union Swiss(Pty) Ltd)
- Merz Pharma
- Dermaclara
- Unilever
제21장 사용된 전제조건과 두자어
제22장 조사 방법
LSH
Persistence Market Research has recently released a comprehensive report on the global stretch marks treatment market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights:
- Stretch Marks Treatment Market Size (2024E): USD 2.9 Billion
- Projected Market Value (2033F): USD 4.6 Billion
- Global Market Growth Rate (CAGR 2024 to 2033): 5.3%
Stretch Marks Treatment Market - Report Scope:
Stretch marks, also known as striae or striae distensae, are a common skin condition that occurs due to rapid stretching of the skin. The stretch marks treatment market encompasses various therapeutic options, including topical treatments, laser therapies, and surgical interventions. These treatments aim to reduce the appearance of stretch marks and improve skin texture. The market serves a wide range of customers, including individuals seeking cosmetic improvements, healthcare providers offering specialized treatments, and aesthetic clinics providing advanced solutions. Market growth is driven by increasing awareness of skin aesthetics, rising prevalence of stretch marks due to lifestyle and hormonal changes, and advancements in treatment technologies.
Market Growth Drivers:
The global stretch marks treatment market is propelled by several key factors, including growing awareness about the availability of effective treatment options. Increasing instances of stretch marks due to factors such as pregnancy, rapid weight gain, and puberty contribute to the rising demand for treatments. Technological advancements, such as the development of non-invasive laser treatments and enhanced topical formulations, offer improved efficacy and patient comfort. Additionally, the increasing emphasis on aesthetic enhancements and cosmetic procedures is driving market expansion. The rise in disposable incomes and the growing trend of personalized skincare further contribute to market growth.
Market Restraints:
Despite promising growth prospects, the stretch marks treatment market faces challenges related to cost and accessibility. The high cost of advanced treatments, such as laser therapies and surgical interventions, can limit accessibility for some individuals. Additionally, the effectiveness of treatments can vary depending on individual skin types and the severity of the stretch marks, which may affect patient satisfaction and treatment outcomes. The market also encounters challenges related to regulatory compliance and the need for continued research to validate treatment efficacy and safety.
Market Opportunities:
The stretch marks treatment market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving consumer preferences. The integration of new technologies, such as radiofrequency and ultrasound-based treatments, offers enhanced treatment options. The increasing focus on personalized skincare solutions and the growing popularity of minimally invasive procedures create new avenues for market players. Strategic partnerships, investment in research and development, and the introduction of affordable and effective treatments are essential to capitalize on emerging opportunities and sustain market leadership.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the stretch marks treatment market globally?
- Which treatment types and applications are driving adoption across different patient demographics?
- How are technological advancements reshaping the competitive landscape of the stretch marks treatment market?
- Who are the key players contributing to the stretch marks treatment market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global stretch marks treatment market?
Competitive Intelligence and Business Strategy:
Leading players in the global stretch marks treatment market, including Allergan PLC, Revance Therapeutics, Inc., and Syneron Candela, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment solutions, including novel topical agents, laser devices, and minimally invasive procedures. Collaborations with dermatologists, aesthetic clinics, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the dynamic stretch marks treatment landscape.
Key Companies Profiled:
- Weleda
- Clarins
- basq NYC
- Body Merry
- Himalaya Global Holdings Ltd.
- Stratpharma AG (Stratpharma Inc.)
- Browne Drug Co., Inc. (Palmer's)
- Mederma (HRA Pharma)
- Givaudan SA
- NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
- Bio-Oil (Union Swiss (Pty) Ltd)
- Merz Pharma
- Dermaclara
- Unilever
Key Segments of Stretch Marks Treatment Industry Research
By Treatment:
- Topical Medications
- Procedural Treatments
By Stretch Mark Type:
- Striae atrophicans (Thinned Skin)
- Striae gravidarum (Post Pregnancy)
- Striae distensae (Stretched Skin)
- striae rubrae (Red)
- Striae albae (White)
- Striae nigra (Black)
- Striae caerulea (Dark Blue)
By End User:
- Hospitals
- Dermatology Clinics
- Aesthetic Clinics
- Wellness and Spa Centers
- Home Care Settings
By Region:
- North America
- Latin America
- Europe Stretch
- South Asia Stretch
- East Asia Stretch
- Oceania Stretch
- The Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 2.3. Inclusions and Exclusions
3. Key Market Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Treatment Type Innovation / Development Trends
4. Key Success Factors
- 4.1. Porter's Analysis
- 4.2. PESTEL Analysis
- 4.3. Dermatologists/Cosmetic Surgeons, Key Country
- 4.4. Dermatology/Cosmetic Surgery Clinics, Key Country
- 4.5. Number of Aesthetic Procedures, By Region
- 4.6. Number of Pregnancy, By Region
- 4.7. Payer Mix Analysis
- 4.8. Promotional Strategies, By Key Players
- 4.9. Healthcare Reimbursement and Financing Structure
- 4.10. Regulatory Scenario
- 4.11. Parent Market Analysis
5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.1.3. Global Life Expectancy Outlook
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increasing Cases of Pregnancy
- 5.2.2. Rising Disposable Per Capita Income
- 5.2.3. Adoption of Aesthetic Treatments
- 5.2.4. Changes in Lifestyle
- 5.2.5. Shift from Invasive to Non-invasive Laser Therapies
- 5.2.6. Presence of Highly Skilled Workforce
- 5.2.7. Media Coverage and Awareness from Celebrities
- 5.2.8. New/Improved Product Launches
- 5.2.9. Growing Investment in Healthcare Expenditure
- 5.2.10. Mergers and Acquisitions
- 5.3. Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
6. COVID-19 Crisis - Impact Assessment
- 6.1. COVID-19 and Impact Analysis
- 6.1.1. By Treatment Type
- 6.1.2. By Stretch Marks Type
- 6.1.3. BY End User
- 6.1.4. By Region
- 6.2. 2023 Market Scenario
7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
- 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
- 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Treatment Type
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Treatment Type, 2019-2023
- 8.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Treatment Type, 2024-2033
- 8.3.1. Topical Medications
- 8.3.1.1. Gels
- 8.3.1.2. Creams
- 8.3.1.3. Oils/Serums
- 8.3.2. Procedural Treatments
- 8.3.2.1. Radiofrequency Therapy
- 8.3.2.2. Nonablative Laser Fractional Resurfacing
- 8.3.2.3. Ablative Laser Resurfacing
- 8.3.2.4. Infrared Devices/Radiations
- 8.3.2.5. Dermabrasion
- 8.3.2.6. Chemical Peel
- 8.4. Market Attractiveness Analysis By Treatment Type
9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Stretch Marks Type
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Bn) Analysis By Stretch Marks Type, 2019-2023
- 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Stretch Marks Type, 2024-2033
- 9.3.1. Striae Atrophicans (Thinned Skin)
- 9.3.2. Striae Gravidarum (Post Pregnancy)
- 9.3.3. Striae Distensae (Stretched Skin)
- 9.3.4. Striae Rubrae (Red)
- 9.3.5. Striae Albae (White)
- 9.3.6. Striae Nigra (Black)
- 9.3.7. Striae Caerulea (Dark Blue)
- 9.4. Market Attractiveness Analysis By Stretch Marks Type
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User
- 10.1. Introduction / Key Findings
- 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
- 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
- 10.3.1. Hospitals
- 10.3.2. Dermatology Clinics
- 10.3.3. Aesthetic Clinics
- 10.3.4. Wellness and Spa Centers
- 10.3.5. Home Care Settings
- 10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
- 11.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. South Asia
- 11.3.5. East Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa (MEA)
- 11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2019-2023 and Forecast 2024-2033
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
- 12.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 12.3.1. By Country
- 12.3.1.1. U.S.
- 12.3.1.2. Canada
- 12.3.2. By Treatment Type
- 12.3.3. By Stretch Marks Type
- 12.3.4. By End User
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Treatment Type
- 12.4.3. By Stretch Marks Type
- 12.4.4. By End User
- 12.5. Country Level Analysis & Forecast
- 12.5.1. U.S. Market Analysis
- 12.5.1.1. .Introduction
- 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 12.5.1.2.1. By Treatment Type
- 12.5.1.2.2. By Stretch Marks Type
- 12.5.1.2.3. By End User
- 12.5.2. Canada Market Analysis
- 12.5.2.1. Introduction
- 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 12.5.2.2.1. By Treatment Type
- 12.5.2.2.2. By Stretch Marks Type
- 12.5.2.2.3. By End User
- 12.6. Market Trends
- 12.7. Key Market Participants - Intensity Mapping
- 12.8. Drivers and Restraints - Impact Analysis
13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
- 13.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 13.3.1. By Country
- 13.3.1.1. Brazil
- 13.3.1.2. Mexico
- 13.3.1.3. Argentina
- 13.3.1.4. Rest of Latin America
- 13.3.2. By Stretch Marks Type
- 13.3.3. By End User
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Treatment Type
- 13.4.3. By Stretch Marks Type
- 13.4.4. By End User
- 13.5. Country Level Analysis & Forecast
- 13.5.1. Brazil Market Analysis
- 13.5.1.1. .Introduction
- 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 13.5.1.2.1. By Treatment Type
- 13.5.1.2.2. By Stretch Marks Type
- 13.5.1.2.3. By End User
- 13.5.2. Mexico Market Analysis
- 13.5.2.1. Introduction
- 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 13.5.2.2.1. By Treatment Type
- 13.5.2.2.2. By Stretch Marks Type
- 13.5.2.2.3. By End User
- 13.5.3. Argentina Market Analysis
- 13.5.3.1. Introduction
- 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 13.5.3.2.1. By Treatment Type
- 13.5.3.2.2. By Stretch Marks Type
- 13.5.3.2.3. By End User
- 13.6. Market Trends
- 13.7. Key Market Participants - Intensity Mapping
- 13.8. Drivers and Restraints - Impact Analysis
14. Europe Market Analysis 2019-2023 and Forecast 2024-2033
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
- 14.3. Market Size (US$ Bn) and Volume (Units) Forecast, By Market Taxonomy, 2024-2033
- 14.3.1. By Country
- 14.3.1.1. Germany
- 14.3.1.2. France
- 14.3.1.3. Italy
- 14.3.1.4. U.K.
- 14.3.1.5. Spain
- 14.3.1.6. Russia
- 14.3.1.7. BENELUX
- 14.3.1.8. Nordic Countries
- 14.3.1.9. Rest of Europe
- 14.3.2. By Treatment Type
- 14.3.3. By Stretch Marks Type
- 14.3.4. By End User
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Treatment Type
- 14.4.3. By Stretch Marks Type
- 14.4.4. By End User
- 14.5. Country Level Analysis & Forecast
- 14.5.1. Germany Market Analysis
- 14.5.1.1. .Introduction
- 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.1.2.1. By Treatment Type
- 14.5.1.2.2. By Stretch Marks Type
- 14.5.1.2.3. By End User
- 14.5.2. France Market Analysis
- 14.5.2.1. Introduction
- 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.2.2.1. By Treatment Type
- 14.5.2.2.2. By Stretch Marks Type
- 14.5.2.2.3. By End User
- 14.5.3. Italy Market Analysis
- 14.5.3.1. Introduction
- 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.3.2.1. By Treatment Type
- 14.5.3.2.2. By Stretch Marks Type
- 14.5.3.2.3. By End User
- 14.5.4. U.K. Market Analysis
- 14.5.4.1. .Introduction
- 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.4.2.1. By Treatment Type
- 14.5.4.2.2. By Stretch Marks Type
- 14.5.4.2.3. By End User
- 14.5.5. Spain Market Analysis
- 14.5.5.1. .Introduction
- 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.5.2.1. By Treatment Type
- 14.5.5.2.2. By Stretch Marks Type
- 14.5.5.2.3. By End User
- 14.5.6. Russia Market Analysis
- 14.5.6.1. .Introduction
- 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.6.2.1. By Treatment Type
- 14.5.6.2.2. By Stretch Marks Type
- 14.5.6.2.3. By End User
- 14.5.7. Nordic Countries Market Analysis
- 14.5.7.1. .Introduction
- 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.7.2.1. By Treatment Type
- 14.5.7.2.2. By Stretch Marks Type
- 14.5.7.2.3. By End User
- 14.5.8. BENELUX Market Analysis
- 14.5.8.1. .Introduction
- 14.5.8.2. Market Analysis and Forecast by Market Taxonomy
- 14.5.8.2.1. By Treatment Type
- 14.5.8.2.2. By Stretch Marks Type
- 14.5.8.2.3. By End User
- 14.6. Market Trends
- 14.7. Key Market Participants - Intensity Mapping
- 14.8. Drivers and Restraints - Impact Analysis
15. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
- 15.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 15.3.1. By Country
- 15.3.1.1. India
- 15.3.1.2. Thailand
- 15.3.1.3. Indonesia
- 15.3.1.4. Malaysia
- 15.3.1.5. Rest of South Asia
- 15.3.2. By Treatment Type
- 15.3.3. By Stretch Marks Type
- 15.3.4. By End User
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Treatment Type
- 15.4.3. By Stretch Marks Type
- 15.4.4. By End User
- 15.5. Country Level Analysis & Forecast
- 15.5.1. India Market Analysis
- 15.5.1.1. .Introduction
- 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.1.2.1. By Treatment Type
- 15.5.1.2.2. By Stretch Marks Type
- 15.5.1.2.3. By End User
- 15.5.2. Thailand Market Analysis
- 15.5.2.1. .Introduction
- 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.2.2.1. By Treatment Type
- 15.5.2.2.2. By Stretch Marks Type
- 15.5.2.2.3. By End User
- 15.5.3. Indonesia Market Analysis
- 15.5.3.1. Introduction
- 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.3.2.1. By Treatment Type
- 15.5.3.2.2. By Stretch Marks Type
- 15.5.3.2.3. By End User
- 15.5.4. Malaysia Market Analysis
- 15.5.4.1. Introduction
- 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 15.5.4.2.1. By Treatment Type
- 15.5.4.2.2. By Stretch Marks Type
- 15.5.4.2.3. By End User
- 15.6. Market Trends
- 15.7. Key Market Participants - Intensity Mapping
- 15.8. Drivers and Restraints - Impact Analysis
16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
- 16.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
- 16.3.1.1. China
- 16.3.1.2. Japan
- 16.3.1.3. South Korea
- 16.3.2. By Treatment Type
- 16.3.3. By Stretch Marks Type
- 16.3.4. By End User
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Treatment Type
- 16.4.3. By Stretch Marks Type
- 16.4.4. By End User
- 16.5. Country Level Analysis & Forecast
- 16.5.1. China Market Analysis
- 16.5.1.1. .Introduction
- 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.1.2.1. By Treatment Type
- 16.5.1.2.2. By Stretch Marks Type
- 16.5.1.2.3. By End User
- 16.5.2. Japan Market Analysis
- 16.5.2.1. Introduction
- 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.2.2.1. By Treatment Type
- 16.5.2.2.2. By Stretch Marks Type
- 16.5.2.2.3. By End User
- 16.5.3. South Korea Market Analysis
- 16.5.3.1. Introduction
- 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.5.3.2.1. By Treatment Type
- 16.5.3.2.2. By Stretch Marks Type
- 16.5.3.2.3. By End User
- 16.6. Market Trends
- 16.7. Key Market Participants - Intensity Mapping
- 16.8. Drivers and Restraints - Impact Analysis
17. Oceania Market Analysis 2019-2023 and Forecast 2024-2033
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
- 17.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
- 17.3.1.1. Australia
- 17.3.1.2. New Zealand
- 17.3.2. By Treatment Type
- 17.3.3. By Stretch Marks Type
- 17.3.4. By End User
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Treatment Type
- 17.4.3. By Stretch Marks Type
- 17.4.4. By End User
- 17.5. Country Level Analysis & Forecast
- 17.5.1. Australia Market Analysis
- 17.5.1.1. .Introduction
- 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.1.2.1. By Treatment Type
- 17.5.1.2.2. By Stretch Marks Type
- 17.5.1.2.3. By End User
- 17.5.2. New Zealand Market Analysis
- 17.5.2.1. Introduction
- 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.5.2.2.1. By Treatment Type
- 17.5.2.2.2. By Stretch Marks Type
- 17.5.2.2.3. By End User
- 17.6. Market Trends
- 17.7. Key Market Participants - Intensity Mapping
- 17.8. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
- 18.3. Market Size (US$ Bn) and Volume (Units) Forecast By Market Taxonomy, 2024-2033
- 18.3.1. By Country
- 18.3.1.1. GCC Countries
- 18.3.1.2. Turkiye
- 18.3.1.3. Northern Africa
- 18.3.1.4. South Africa
- 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Treatment Type
- 18.3.3. By Stretch Marks Type
- 18.3.4. By End User
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Treatment Type
- 18.4.3. By Stretch Marks Type
- 18.4.4. By End User
- 18.5. Country Level Analysis & Forecast
- 18.5.1. GCC Countries Market Analysis
- 18.5.1.1. .Introduction
- 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.1.2.1. By Treatment Type
- 18.5.1.2.2. By Stretch Marks Type
- 18.5.1.2.3. By End User
- 18.5.2. Turkiye Market Analysis
- 18.5.2.1. Introduction
- 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.2.2.1. By Treatment Type
- 18.5.2.2.2. By Stretch Marks Type
- 18.5.2.2.3. By End User
- 18.5.3. Northern Africa Market Analysis
- 18.5.3.1. Introduction
- 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.3.2.1. By Treatment Type
- 18.5.3.2.2. By Stretch Marks Type
- 18.5.3.2.3. By End User
- 18.5.4. South Africa Market Analysis
- 18.5.4.1. Introduction
- 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
- 18.5.4.2.1. By Treatment Type
- 18.5.4.2.2. By Stretch Marks Type
- 18.5.4.2.3. By End User
- 18.6. Market Trends
- 18.7. Key Market Participants - Intensity Mapping
- 18.8. Drivers and Restraints - Impact Analysis
19. Market Structure Analysis
- 19.1. Market Analysis by Tier of Companies
- 19.2. Market Share Analysis of Top Players
- 19.3. Market Presence Analysis
20. Competition Analysis
- 20.1. Competition Dashboard
- 20.2. Competition Benchmarking
- 20.3. Competition Deep Dive
- 20.3.1. Weleda
- 20.3.1.1. Overview
- 20.3.1.2. Treatment Type Portfolio
- 20.3.1.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.1.4. Sales Footprint
- 20.3.1.5. Strategy Overview
- 20.3.2. Clarins
- 20.3.2.1. Overview
- 20.3.2.2. Treatment Type Portfolio
- 20.3.2.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.2.4. Sales Footprint
- 20.3.2.5. Strategy Overview
- 20.3.3. basq NYC
- 20.3.3.1. Overview
- 20.3.3.2. Treatment Type Portfolio
- 20.3.3.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.3.4. Sales Footprint
- 20.3.3.5. Strategy Overview
- 20.3.4. Body Merry
- 20.3.4.1. Overview
- 20.3.4.2. Treatment Type Portfolio
- 20.3.4.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.4.4. Sales Footprint
- 20.3.4.5. Strategy Overview
- 20.3.5. Himalaya Global Holdings Ltd.
- 20.3.5.1. Overview
- 20.3.5.2. Treatment Type Portfolio
- 20.3.5.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.5.4. Sales Footprint
- 20.3.5.5. Strategy Overview
- 20.3.6. Stratpharma AG (Stratpharma Inc.)
- 20.3.6.1. Overview
- 20.3.6.2. Treatment Type Portfolio
- 20.3.6.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.6.4. Sales Footprint
- 20.3.6.5. Strategy Overview
- 20.3.7. Browne Drug Co., Inc. (Palmer's)
- 20.3.7.1. Overview
- 20.3.7.2. Treatment Type Portfolio
- 20.3.7.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.7.4. Sales Footprint
- 20.3.7.5. Strategy Overview
- 20.3.8. Mederma (HRA Pharma)
- 20.3.8.1. Overview
- 20.3.8.2. Treatment Type Portfolio
- 20.3.8.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.8.4. Sales Footprint
- 20.3.8.5. Strategy Overview
- 20.3.9. Givaudan SA
- 20.3.9.1. Overview
- 20.3.9.2. Treatment Type Portfolio
- 20.3.9.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.9.4. Sales Footprint
- 20.3.9.5. Strategy Overview
- 20.3.10. NEOSTRATA COMPANY, INC. (Johnson & Johnson Services, Inc.)
- 20.3.10.1. Overview
- 20.3.10.2. Treatment Type Portfolio
- 20.3.10.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.10.4. Sales Footprint
- 20.3.10.5. Strategy Overview
- 20.3.11. Bio-Oil (Union Swiss (Pty) Ltd)
- 20.3.11.1. Overview
- 20.3.11.2. Treatment Type Portfolio
- 20.3.11.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.11.4. Sales Footprint
- 20.3.11.5. Strategy Overview
- 20.3.12. Merz Pharma
- 20.3.12.1. Overview
- 20.3.12.2. Treatment Type Portfolio
- 20.3.12.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.12.4. Sales Footprint
- 20.3.12.5. Strategy Overview
- 20.3.13. Dermaclara
- 20.3.13.1. Overview
- 20.3.13.2. Treatment Type Portfolio
- 20.3.13.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.13.4. Sales Footprint
- 20.3.13.5. Strategy Overview
- 20.3.14. Unilever
- 20.3.14.1. Overview
- 20.3.14.2. Treatment Type Portfolio
- 20.3.14.3. Profitability by Market Segments (Treatment Type/Region)
- 20.3.14.4. Sales Footprint
- 20.3.14.5. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
